MarketCap
Facebook
X
Telegram
Land |
 Vereinigte Staaten |
IPO-Jahr |
2020 |
Branche |
Pharmaeinzelhändler |
Börse |
NASDAQ GLOBAL |
Anteile |
46.6 M |
Marktkapitalisierung |
$ 123 M |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Andere Aktien der Branche "Pharmaeinzelhändler"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Annexon
ANNX
|
$ 4.21 | 4.99 % | $ 653 M | Nasdaq Global Select Market | USA |
 |
AbbVie
ABBV
|
$ 291.22 | 1.06 % | $ 515 B | NYSE,SPB | USA |
 |
22nd Century Group
XXII
|
$ 1.56 | -19.17 % | $ 287 K | NYSE American | USA |
 |
Axon Enterprise
AXON
|
$ 313.68 | -18.01 % | $ 24.5 B | Nasdaq Global Select Market,SPB | USA |
 |
Biogen
BIIB
|
$ 248.51 | 1.88 % | $ 36.4 B | Nasdaq Global Select Market,SPB | USA |
 |
BioLineRx Ltd.
BLRX
|
$ 1.73 | -2.15 % | $ 4.26 B | Nasdaq Capital Market |  Israel |
 |
Theratechnologies
THTX
|
- | - | $ 83.9 M | Nasdaq Capital Market |  Canada |
 |
Exelixis
EXEL
|
$ 69.55 | 1.22 % | $ 18.9 B | Nasdaq Global Select Market,SPB | USA |
 |
Geron Corporation
GERN
|
$ 0.99 | 3.97 % | $ 660 M | Nasdaq Global Select Market | USA |
 |
Gilead Sciences
GILD
|
$ 166.9 | -0.4 % | $ 208 B | Nasdaq Global Select Market,SPB | USA |
 |
Grifols, S.A.
GRFS
|
$ 8.46 | -0.12 % | $ 5.75 B | Nasdaq Global Select Market |  Spain |
 |
Alnylam Pharmaceuticals
ALNY
|
$ 155.97 | -0.44 % | $ 20.4 B | Nasdaq Global Select Market,SPB | USA |
 |
InflaRx N.V.
IFRX
|
$ 1.31 | -3.69 % | $ 88.1 M | Nasdaq Global Select Market |  Germany |
 |
INmune Bio
INMB
|
$ 1.12 | -4.68 % | $ 27.7 M | Nasdaq Capital Market | USA |
 |
Insmed Incorporated
INSM
|
$ 114.55 | 5.32 % | $ 22.8 B | Nasdaq Global Select Market | USA |
 |
Johnson & Johnson
JNJ
|
$ 274.89 | 0.95 % | $ 662 B | NYSE,SPB | USA |
 |
Titan Pharmaceuticals
TTNP
|
- | -3.76 % | $ 3.47 M | Nasdaq Capital Market | USA |
 |
Lineage Cell Therapeutics
LCTX
|
$ 1.02 | 3.75 % | $ 235 M | NYSE American | USA |
 |
BioVie
BIVI
|
$ 1.33 | 9.92 % | $ 1.96 M | Nasdaq Capital Market | USA |
 |
Longeveron
LGVN
|
$ 1.82 | 6.43 % | $ 32 B | Nasdaq Global Select Market | USA |
 |
Allena Pharmaceuticals
ALNA
|
- | 3.16 % | $ 1.9 M | Nasdaq Global Select Market | USA |
 |
TCR2 Therapeutics
TCRR
|
- | - | $ 58.1 M | Nasdaq Global Select Market,SPB | USA |
 |
Crinetics Pharmaceuticals
CRNX
|
$ 84.95 | 0.13 % | $ 7.99 B | Nasdaq Global Select Market | USA |
 |
Mustang Bio
MBIO
|
$ 0.39 | 0.15 % | $ 1.91 M | Nasdaq Global Market | USA |
 |
TFF Pharmaceuticals
TFFP
|
- | -60.05 % | $ 125 K | Nasdaq Global Select Market | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
$ 1.63 | 1.87 % | $ 2.68 M | NYSE American | Israel |
 |
Mesoblast Limited
MESO
|
$ 14.26 | 1.13 % | $ 17.2 B | Nasdaq Global Select Market |  Australia |
 |
Mirum Pharmaceuticals
MIRM
|
$ 93.81 | 0.28 % | $ 4.71 B | Nasdaq Global Select Market | USA |
 |
Adaptimmune Therapeutics plc
ADAP
|
- | -15.15 % | $ 60.3 M | Nasdaq Global Select Market |  Britain |
 |
AVEO Pharmaceuticals
AVEO
|
- | - | $ 521 M | Nasdaq Capital Market | USA |
 |
Codexis
CDXS
|
$ 1.09 | 6.37 % | $ 95 M | Nasdaq Global Select Market | USA |
 |
MannKind Corporation
MNKD
|
$ 3.91 | 4.0 % | $ 1.2 B | Nasdaq Global Market | USA |
 |
MediciNova
MNOV
|
$ 1.44 | -0.69 % | $ 70.7 M | Nasdaq Global Market | USA |
 |
Axcella Health
AXLA
|
- | -16.42 % | $ 249 M | Nasdaq Global Market | USA |
 |
Merck & Co.
MRK
|
$ 146.81 | -0.07 % | $ 367 B | NYSE,SPB | USA |
 |
Dynavax Technologies Corporation
DVAX
|
- | - | $ 2.02 B | Nasdaq Capital Market | USA |
 |
Tyme Technologies
TYME
|
- | 8.07 % | $ 54 M | Nasdaq Capital Market | USA |
 |
Curis
CRIS
|
$ 0.88 | 3.67 % | $ 11.6 M | Nasdaq Global Market | USA |
 |
Cyclerion Therapeutics
CYCN
|
$ 34.99 | 3.77 % | $ 147 M | Nasdaq Global Select Market | USA |
 |
Завод ДИОД
DIOD
|
- | - | - | MOEX,SPB |  Russia |
 |
CorMedix
CRMD
|
$ 5.31 | 1.43 % | $ 383 K | Nasdaq Global Market | USA |
 |
Novartis AG
NVS
|
$ 162.64 | 0.44 % | $ 315 B | NYSE |  Schweiz |
 |
CRISPR Therapeutics AG
CRSP
|
$ 50.09 | 3.15 % | $ 4.5 B | Nasdaq Global Market,SPB | Schweiz |
 |
PDS Biotechnology Corporation
PDSB
|
$ 1.22 | 4.27 % | $ 56.6 M | Nasdaq Capital Market | USA |
 |
Pfizer
PFE
|
$ 29.39 | -0.22 % | $ 167 B | NYSE,SPB | USA |
 |
Pharming Group N.V.
PHAR
|
$ 12.32 | 0.16 % | $ 8.49 B | Nasdaq Global Select Market |  Niderland |
 |
Orgenesis
ORGS
|
- | -33.86 % | $ 61.2 M | Nasdaq Capital Market | USA |
 |
Cytokinetics, Incorporated
CYTK
|
$ 53.74 | -3.26 % | $ 6.45 M | Nasdaq Global Select Market,SPB | USA |
 |
Фармсинтез
LIFE
|
- | - | - | MOEX | Russia |
 |
Prothena Corporation plc
PRTA
|
$ 7.93 | 0.51 % | $ 427 M | Nasdaq Global Select Market,SPB | USA |